The use of celecoxib for reduction of pain after subpectoral breast augmentation

Aesthetic Plastic Surgery

Volumn 29, Issue 6, 2005, Pages 441-444

  Parsa, Alan A ^a,b   Soon, Christopher W M ^a   Don Parsa, Fereydoun ^a  

^a John A Burns School of Medicine ^*

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Breast implants; Celebrex; Celecoxib; Pain after breast surgery; Pain and Subpectoral breast augmentation

Indexed keywords

CELECOXIB; HYDROCODONE; OPIATE; PARACETAMOL; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BREAST AUGMENTATION; BREAST HYPOPLASIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPARA; NAUSEA; NULLIPARA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SMOKING HABIT;

ADOLESCENT; ADULT; CYCLOOXYGENASE INHIBITORS; FEMALE; HUMANS; MAMMAPLASTY; MIDDLE AGED; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PECTORALIS MUSCLES; PYRAZOLES; SULFONAMIDES;

EID: 29744467492     PISSN: 0364216X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00266-005-0032-1     Document Type: Article

References (24)

1. Bekker A, Cooper PR, Frempong-Boadu A, Babu R, Errico T, Lebovits A: Evaluation of preoperative administration of the cyclooxygenase-2 inhibitor rofecoxib for treatment of postoperative pain after lumbar disk surgery. Neurosurgery 50:1053-1057, 2002
2. Creekmore FM, Lugo RA, Weiland KJ: Postoperative opiate analgesia requirements of smokers and non-smokers. Ann Pharmacother 38:949-953, 2004
3. Desjardins PJ, Shu VS, Recker DP, Verburg KM, Woolf CJ: A single preoperative oral dose of valdecoxib, a new cyclooxygenase-2 specific inhibitor, relieves postoral surgery or bunionectomy pain. Anesthesiology 97:565-573, 2002
4. Glasson JC, Sawyer WT, Lindley CM, Ginsberg B: Patient-specific factors affecting patient-controlled analgesia dosing. J Pain Palliat Care Pharmacother 16:5-21, 2002
5. Hollander D: Gastrointestinal complications of non-steroidal antiinflammatory drugs: Prophylactic and therapeutic strategies. Am J Med 96:274-281, 1994
6. Houston AM, Teach SJ: COX-2 inhibitors: A review. Pediatr Emerg Care 20:396-399, 2004
7. Issioui T, Klein KW, White PF, Watcha MF, Skrivanek GD, Jones SB, Hu J, Marple BF, Ing C: Cost-efficacy of rofecoxib versus acetaminophen for preventing pain after ambulatory surgery. Anesthesiology 97:931-937, 2002
8. Karamanlioglu B, Arar C, Alagol A, Colak A, Gemlik I, Sut N: Preoperative oral celecoxib versus preoperative oral rofecoxib for pain relief after thyroid surgery. Eur J Anaesthesiol 20:490-495, 2003
9. Karamanlioglu B, Turan A, Memis D, Ture M: Preoperative oral rofecoxib reduces postoperative pain and tramadol consumption in patients after abdominal hysterectomy. Anesth Analg 98:1039-1043, 2004
10. Knijff-Dutmer EA, Kalsbeek-Batenburg EM, Koerts J, van de Laar MA: Platelet function is inhibited by nonselective nonsteroidal antiinflammatory drugs but not by cyclooxygenase-2-selective inhibitors in patients with rheumatoid arthritis. Rheumatology (Oxford) 41:458-461, 2002
11. Malmstrom K, Daniels S, Kotey P, Seidenberg BC, Desjardins PJ: Comparison of rofecoxib and celecoxib, two cyclooxygenase-2 inhibitors in postoperative dental pain: A randomized, placebo- and active-comparator-controlled clinical trial. Clin Ther 21:1653-1663, 1999
12. Mamdani M, Juurlink DN, Lee DS, Rochon PA, Kopp A, Naglie G, Austin PC, Laupacis A, Stukel TA: Cyclooxygenase-2 inhibitors versus nonselective nonsteroidal antiinflammatory drugs and congestive heart failure outcomes in elderly patients: A population-based cohort study. Lancet 363:1751-1756, 2004
13. Needleman P, Isakson PC: The discovery and function of COX-2. J Rheumatol 24:6-7, 1997
14. Recart A, Issioui T, White PF, Klein K, Watcha MF, Stool L, Shah M: The efficacy of celecoxib premedication on postoperative pain and recovery times after ambulatory surgery: A dose-ranging study. Anesth Analg 96:1631-1635, 2003
15. Reicin A, Brown J, Jove M, deAndraded JR, Bourne M, Krupa D, Walters D, Seidenberg B: Efficacy of single-dose and multidose rofecoxib in the treatment of postorthopedic surgery pain. Am J Orthop 30:40-48, 2001
16. Reuben SS, Connelly NR: Postoperative analgesic effects of celecoxib or rofecoxib after spinal fusion surgery. Anesth Analg 91:1221-1225, 2000
17. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, Burr AM, Zhao WW, Kent JD, Lefkowith JB, Verburg KM, Geis GS: Gastrointestinal toxicity with celecoxib vs nonsteroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284:1247-1255, 2000
18. Simon LS: Nonsteroidal antiinflammatory drugs and their effects: The importance of COX "selectivity." J Clin Rheumatol 2:135-140, 1996
19. Simon LS: Role and regulation of cyclooxygenase-2 during inflammation. Am J Med 106:S37-S42, 1999
20. Sinclair Chung DR F, Mezei G: Can postoperative nausea and vomiting be predicted? Anesthesiology 91:109-118, 1999
21. Solomon DH, Schneeweiss S, Glynn RJ, Kiyota Y, Levin R, Mogun H, Avorn J: Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation 109:2068-2073, 2004
22. Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, Bertagnolli M (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352:1071-1080, 2005
23. Watcha MF, Issioui T, Klein KW, White PF: Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory surgery. Anesth Analg 96:987-994, 2003
24. White WB, Faich G, Borer JS, Makuch RW: Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib. Am J Cardiol 92:411-418, 2003